Arkolith/Insider Trading/SMMT/Form 4

Zanganeh Mahkam

Chief Executive Officer, DirectorSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Dec 13, 2023
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2023Buy(P)5K$2.07$10K495K
Dec 11, 2023Option exercise(X)316K$1.58$499K24.9M
Dec 11, 2023Option exercise(X)490K$1.44$705K490K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 11, 2023Option exercise(X)316K—$00
Dec 11, 2023Option exercise(X)490K—$00

Transaction Codes

P
Open-market purchase
X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599298-23-000103) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML